Source: C l i n i c a l Immunology. Unidade: FM
Subjects: DOENÇAS GENÉTICAS, CRIANÇAS, BRASILEIROS, MUTAÇÃO GENÉTICA, IMUNOGLOBULINAS, SEQUENCIAMENTO GENÉTICO
ABNT
CARATÃO, Nadine et al. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome. C l i n i c a l Immunology, v. 148, n. 2, p. 279-286, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2013.05.017. Acesso em: 18 nov. 2024.APA
Caratão, N., Cortesão, C. S., Reis, P. H., Freitas, R. F., Jacob, C. M. A., Pastorino, A. C., et al. (2013). A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome. C l i n i c a l Immunology, 148( 2), 279-286. doi:10.1016/j.clim.2013.05.017NLM
Caratão N, Cortesão CS, Reis PH, Freitas RF, Jacob CMA, Pastorino AC, Carneiro-Sampaio M, Barreto VM. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome [Internet]. C l i n i c a l Immunology. 2013 ; 148( 2): 279-286.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.clim.2013.05.017Vancouver
Caratão N, Cortesão CS, Reis PH, Freitas RF, Jacob CMA, Pastorino AC, Carneiro-Sampaio M, Barreto VM. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome [Internet]. C l i n i c a l Immunology. 2013 ; 148( 2): 279-286.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.clim.2013.05.017